Market Place
Sourcing Support
Abbvie Halts Development Of Dragonfly Cancer Asset In Midflight
29 Oct 2025 //
FIERCE BIOTECH
Zag Bio Emerges With $80M Funding For Tregs Diabetes Candidate
28 Oct 2025 //
FIERCE BIOTECH
Abbvie`s Rinvoq Beats Humira In Key Arthritis Trial
22 Oct 2025 //
INDPHARMAPOST
BOTOX® Cosmetic`s Confidence Project Reveals Grant Recipients
21 Oct 2025 //
PR NEWSWIRE
Upadacitinib Outperforms Adalimumab In Rheumatoid Arthritis Study
20 Oct 2025 //
PR NEWSWIRE
AbbVie Completes Acquisition of Gilgamesh Pharma` Bretisilocin
17 Oct 2025 //
PR NEWSWIRE
Enveric Bio Hires IP Firm to Defend Patent Linked to AbbVie Deal
15 Oct 2025 //
PHARMIWEB
FDA Approves Abbvie`s Upadacitinib For Inflammatory Bowel Disease
14 Oct 2025 //
PRESS RELEASE
Abbvie Presents ADC Data For Hard-To-Treat Cancers At ESMO 2025
14 Oct 2025 //
INDPHARMAPOST
Abbvie Showcases Solid Tumor Targeted Therapy Leadership At ESMO
13 Oct 2025 //
PR NEWSWIRE
Allergan Aesthetics Launches Skinmedica`s Reimagined Packaging
11 Oct 2025 //
INDPHARMAPOST
Abbvie Taps Tyler James Williams For New IBD Campaign
07 Oct 2025 //
FIERCE PHARMA
AbbVie Reports Positive Ph2 ELATE Data for Botox in Tremor
06 Oct 2025 //
PRESS RELEASE
Abbvie`s Natrelle Awarded Supplier Agreement From Vizient
05 Oct 2025 //
INDPHARMAPOST
Abbvie Cuts Annual Profit Forecast Due To Anticipated $2.7B R&D
03 Oct 2025 //
REUTERS
Calico Gets FDA Fast Track for ADPKD Investigational Treatment
02 Oct 2025 //
PR NEWSWIRE
Abbvie, Beone End BTK Inhibitor Patent Fight
02 Oct 2025 //
FIERCE PHARMA
Natrelle® Awarded Supplier Agreement From Vizient
01 Oct 2025 //
PR NEWSWIRE
Abbvie Commences $70m Biologics Manufacturing Site Construction
01 Oct 2025 //
FIERCE PHARMA
Bms, Takeda Join Peers In Push To Improve AI By Pooling Data
01 Oct 2025 //
FIERCE BIOTECH
Abbvie Files BLA For Pivekimab Sunirine To Treat Rare Cancer
30 Sep 2025 //
PR NEWSWIRE
AbbVie Breaks Ground on Chicago API Manufacturing Plant
30 Sep 2025 //
PRESS RELEASE
Nxera Pharma To Get $10M Milestone Payment From Abbvie
29 Sep 2025 //
GLOBENEWSWIRE
Abbvie Files Tavapadon NDA With US FDA For Parkinson`s Disease
26 Sep 2025 //
PR NEWSWIRE
Arcturus Sues AbbVie Over Drug-Delivery Trade Secrets
24 Sep 2025 //
REUTERS
Abbvie Enters Psychedelics Space, Signaling New Era
22 Sep 2025 //
BIOSPACE
AbbVie Shares Hit Record on Immunology Drug Exclusivity Till 2037
12 Sep 2025 //
REUTERS
Glenmark Innovation Receives Upfront Payment of 700 M from AbbVie
10 Sep 2025 //
INDPHARMAPOST
BOTOX® Cosmetic Launches `The One & Only` Campaign with Stories
09 Sep 2025 //
PR NEWSWIRE
AbbVie`s Skyrizi, Rinvoq led TV drug ad spending again in August
05 Sep 2025 //
FIERCE PHARMA
Abbvie Inc`s Biologics Skyrizi Receives Suppl Approval in US
03 Sep 2025 //
FDA
AbbVie to Present at Morgan Stanley Global Healthcare Conference
02 Sep 2025 //
PR NEWSWIRE
AbbVie’s Elahere Approved in Canada
29 Aug 2025 //
HEALTH CANADA
AbbVie-Partnered Protein Degrader Specialist Plexium raises $60M
29 Aug 2025 //
FIERCE BIOTECH
AbbVie Buys Gilgamesh’s Depression Drug for $1.2B
26 Aug 2025 //
PRESS RELEASE
Abbvie Posts Successful Results from 2nd Rinvoq Alopecia Study
22 Aug 2025 //
PRESS RELEASE
AbbVie Honors Patients, Scientists Behind Its Medicines
21 Aug 2025 //
FIERCE PHARMA
AbbVie Completes Acquisition of Capstan Therapeutics
20 Aug 2025 //
PRESS RELEASE
AbbVie plans $195M API plant in Illinois
13 Aug 2025 //
PRESS RELEASE
AbbVie`s Rinvoq Produces Stellar Results in Alopecia Study
05 Aug 2025 //
FIERCE PHARMA
AbbVie Halts IL-1 Asset Development for Ulcerative Colitis
31 Jul 2025 //
FIERCE BIOTECH
AbbVie Celebrates as Skyrizi and Rinvoq Generate Billions
31 Jul 2025 //
BIOSPACE
AbbVie`s Financial Results for Q2 2025 Released
31 Jul 2025 //
PR NEWSWIRE
AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal
31 Jul 2025 //
REUTERS
AbbVie`s Phase 3 Trial of Upadacitinib for Alopecia Areata
30 Jul 2025 //
PRESS RELEASE
Lilly`s BTK Jaypirca Outperforms Imbruvica in Trials
30 Jul 2025 //
FIERCE PHARMA
Abbvie Submitted sNDA for Venetoclax in Untreated CLL
30 Jul 2025 //
PRESS RELEASE
AbbVie, Gilead, GSK Support Annual Hepatitis Elimination Drive
29 Jul 2025 //
FIERCE PHARMA
AbbVie awarded $56M in Botox patent infringement case
23 Jul 2025 //
FIERCE PHARMA
AbbVie Wins $56M in Botox Patent Case
22 Jul 2025 //
FIERCE PHARMA
Botox Cosmetic Picks Entrepreneurs for Confidence Project
22 Jul 2025 //
PR NEWSWIRE
6 Companies Hiring in Illinois
17 Jul 2025 //
BIOSPACE
AbbVie`s Skyrizi, Novo`s Wegovy Top Q2 TV Ad Spending
16 Jul 2025 //
FIERCE PHARMA
AbbVie & IGI Ink Global Deal For ISB 2001 Licensing Rights
12 Jul 2025 //
PRESS RELEASE
AbbVie to buy Capstan for up to $2.1B in Immunology Push
01 Jul 2025 //
PRESS RELEASE
AbbVie to Host Second-Quarter 2025 Earnings Conference Call
30 Jun 2025 //
PR NEWSWIRE
Turnstone, once allied with AbbVie, accepts $8M Xoma buyout
30 Jun 2025 //
FIERCE BIOTECH
Despite revision, UCPMP remains toothless: Alleges FMRAI
23 Jun 2025 //
PHARMABIZ
AbbVie Declares Quarterly Dividend
20 Jun 2025 //
PRESS RELEASE
AbbVie`s Migraine Drug Meets Main Goal in Head-To-Head Study
19 Jun 2025 //
PRESS RELEASE
